Background and Aim: Investigations on chemical enhancement of skin penetration of gold nanoparticles are considered crucial to have a deeper insight into the main barrier of particle penetration. Methods: In this study, penetration of gold nanoparticles in the presence of several chemical enhancers – urea, sodium lauryl sulphate, polysorbate 80 and dimethyl sulfoxide (DMSO) – through human skin was studied. Results: Among the tested chemical enhancers, DMSO could induce the penetration of hydrophilic (citrate-stabilized) gold colloid of no intrinsic penetration ability in a concentration-dependent manner. Pretreatment of the skin with DMSO however reduced the penetration of hydrophobic (cetrimide-coated) gold nanoparticles as a result of aggregation in the top layers of the stratum corneum limiting penetration into the deeper skin layers. In addition, nanoparticles-vehicle interaction and the stability of the nanoparticles in the applied vehicle were found important determinants of skin penetration. Conclusion: Our results demonstrate that the already established approaches for chemical permeation enhancement of drug molecules and their postulated mechanisms could be used as preliminary guidelines for enhancing the penetration of nanoparticles. At this size range of 15 nm, intercellular lipids provide the main barrier to particle penetration through the stratum corneum.

Keywords:
Particle penetration, Chemical penetration enhancement, Gold nanoparticles, Multiphoton microscopy
1.
Wertz PW: Lipids and barrier function of the skin. Acta Derm Venereol Suppl (Stockh) 2000;208:7–11.
2.
Thong HY, Zhai H, Maibach HI: Percutaneous penetration enhancers: an overview. Skin Pharmacol Physiol 2007;20:272–282.
3.
Kuo TR, Wu CL, Hsu CT, Lo W, Chiang SJ, Lin SJ, Dong CY, Chen CC: Chemical enhancer induced changes in the mechanisms of transdermal delivery of zinc oxide nanoparticles. Biomaterials 2009;30:3002–3008.
4.
Gopee NV, Roberts DW, Webb P, Cozart CR, Siitonen PH, Latendresse JR, Warbitton AR, Yu WW, Colvin VL, Walker NJ, Howard PC: Quantitative determination of skin penetration of PEG-coated CdSe quantum dots in dermabraded but not intact SKH-1 hairless mouse skin. Toxicol Sci 2009;111:37–48.
5.
Xia XR, Monteiro-Riviere NA, Riviere JE: Skin penetration and kinetics of pristine fullerenes (C60) topically exposed in industrial organic solvents. Toxicol Appl Pharmacol 2010;242:29–37.
6.
Schneider M, Stracke F, Hansen S, Schaefer UF: Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol 2009;1:197–206.
7.
Bolzinger MA, Briançon S, Chevalier Y: Nanoparticles through the skin: managing conflicting results of inorganic and organic particles in cosmetics and pharmaceutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3:463–478.
8.
Labouta HI, Kraus T, El-Khordagui LK, Schneider M: Combined multiphoton imaging-pixel analysis for semiquantitation of skin penetration of gold nanoparticles. Int J Pharm 2011;413:279–282.
9.
Labouta HI, Hampel M, Thude S, Reutlinger K, Kostka KH, Schneider M: Depth profiling of gold nanoparticles and characterization of point spread functions in reconstructed and human skin using multiphoton microscopy. J Biophotonics 2011;5:85–96.
10.
Ghosh P, Han G, De M, Kim CK, Rotello VM: Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008;60:1307–1315.
11.
Pissuwan D, Niidome T, Cortie MB: The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release 2011;149:65–71.
12.
Labouta HI, Schneider M: Tailor-made biofunctionalized nanoparticles using layer-by-layer technology. Int J Pharm 2010;395:236–242.
13.
Brown SD, Nativo P, Smith JA, Stirling D, Edwards PR, Venugopal B, Flint DJ, Plumb JA, Graham D, Wheate NJ: Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 2010;132:4678–4684.
14.
Chen YH, Tsai CY, Huang PY, Chang MY, Cheng PC, Chou CH, Chen DH, Wang CR, Shiau AL, Wu CL: Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharm 2007;4:713–722.
15.
Reum N, Fink-Straube C, Klein T, Hartmann RW, Lehr CM, Schneider M: Multilayer coating of gold nanoparticles with drug-polymer coadsorbates. Langmuir 2010;26:16901–16908.
16.
Bhumkar D, Joshi H, Sastry M, Pokharkar V: Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res 2007;24:1415–1426.
17.
Wang H, Huang H, Huang X: Differential effects of abscisic acid and ethylene on the fruit maturation of litchi chinensis Sonn. Plant Growth Regul 2007;52:189–198.
18.
Thomas M, Klibanov AM: Conjugation to gold nanoparticles enhances polyethylenimine’s transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA 2003;100:9138–9143.
19.
Oishi M, Nakaogami J, Ishii T, Nagasaki Y: Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing. Chem Lett 2006;35:1046–1047.
20.
Huang X, Qian W, El-Sayed IH, El-Sayed MA: The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy. Lasers Surg Med 2007;39:747–753.
21.
Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino K: In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf B Biointerfaces 2008;65:1–10.
22.
Krishnan G, Edwards J, Chen Y, Benson HA: Enhanced skin permeation of naltrexone by pulsed electromagnetic fields in human skin in vitro. J Pharm Sci 2010;99:2724–2731.
23.
Larese Filon F, Crosera M, Adami G, Bovenzi M, Rossi F, Maina G: Human skin penetration of gold nanoparticles through intact and damaged skin. Nanotoxicology 2011;5:493–501.
24.
Seto JE, Polat BE, Lopez RFV, Blankschtein D, Langer R: Effects of ultrasound and sodium lauryl sulfate on the transdermal delivery of hydrophilic permeants: comparative in vitro studies with full-thickness and split-thickness pig and human skin. J Control Release 2010;145:26–32.
25.
Lademann J, Patzelt A, Richter H, Antoniou C, Sterry W, Knorr F: Determination of the cuticula thickness of human and porcine hairs and their potential influence on the penetration of nanoparticles into the hair follicles. J Biomed Opt 2009;14:021014.
26.
Patzelt A, Richter H, Knorr F, Schaefer U, Lehr CM, Dahne L, Sterry W, Lademann J: Selective follicular targeting by modification of the particle sizes. J Control Release 2011;150:45–48.
27.
Turkevich J, Stevenson PC, Hillier J: A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951;11:55–57.
28.
Labouta HI, Kraus T, El-Khordagui LK, Schneider M: Mechanism and determinants of nanoparticle penetration through human skin. Nanoscale 2011;3:4989–4999.
29.
Wagner H, Kostka KH, Adelhardt W, Schaefer UF: Effects of various vehicles on the penetration of flufenamic acid into human skin. Eur J Pharm Biopharm 2004;58:121–129.
30.
Labouta HI, Liu DC, Lin LL, Butler MK, Jeffrey GE, Raphael A, Kraus T, El-Khordagui LK, Soyer HP, Roberts MS, Schneider M, Prow TW: Gold nanoparticle penetration and reduced metabolism in human skin by toluene. Pharm Res 2011;28:2931–2944.
31.
Schneider G, Decher G: Functional core/shell nanoparticles via layer-by-layer assembly. Investigation of the experimental parameters for controlling particle aggregation and for enhancing dispersion stability. Langmuir 2008;24:1778–1789.
32.
Weisbecker CS, Merritt MV, Whitesides GM: Molecular self-assembly of aliphatic thiols on gold golloids. Langmuir 1996;12:3763–3772.
33.
Asbill CS, Michniak BB: Percutaneous penetration enhancers: local versus transdermal activity. Pharm Sci Technolo Today 2000;3:36–41.
34.
Walters KA, Bialik W, Brain KR: The effects of surfactants on penetration across the skin. Int J Cosmet Sci 1993;15:260–271.
35.
Anigbogu ANC, Williams AC, Barry BW, Edwards HGM: Fourier transform raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum. Int J Pharm 1995;125:265–282.
36.
Roberts MS, Gierden A, Riviere JE, Monteiro-Riviere NA: Solvent and vehicle effects on the skin; in Roberts MS, Walters KA (eds): Dermal Absorption and Toxicity Assessment. New York, Informa Healthcare USA, Inc., 2008, pp 433–448.
37.
Lawrence HJ, Walsh D, Zapotowski KA, Denham A, Goodnight SH, Gandara DR: Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation. Cancer Chemother Pharmacol 1989;23:316–318.
38.
Roth SH, Fuller P: Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis. J Pain Res 2011;4:159–167.
39.
Wong KK, Wang GM, Dreyfuss J, Schreiber EC: Absorption, excretion, and biotransformation of dimethyl sulfoxide in man and miniature pigs after topical application as an 80% gel. J Investig Dermatol 1971;56:44–48.
40.
Sulzberger MB, Cortese TA, Jr., Fishman L, Wiley HS, Peyakovich PS: Some effects of DMSO on human skin in vivo. Ann N Y Acad Sci 1967;141:437–450.
41.
John H, Laudahn G: Clinical experiences with the topical application of DMSO in orthopedic diseases: evaluation of 4180 cases. Ann N Y Acad Sci 1967;141:506–516.
42.
Brechner VL, Cohen DD, Pretsky I: Dermal anesthesia by the topical application of tetracaine base dissolved in dimethyl sulfoxide. Ann N Y Acad Sci 1967;141:524–531.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.